Exicure (XCUR) Other Non-Current Assets (2016 - 2026)
Exicure (XCUR) reported Other Non-Current Assets of $821000.0 for Q1 2026, down 43.34% on a YoY basis from $1.4 million in Q1 2025, and down 11.53% quarter-over-quarter from $928000.0 in Q4 2025.
Exicure (XCUR) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Exicure has reported Other Non-Current Assets for 11 years, with the latest figure at $821000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 43.34% year-over-year to $821000.0; the trailing twelve-month figure through Mar 2026 stood at $821000.0 (down 43.34% YoY), and the FY2025 full-year result was $928000.0, down 31.61% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $821000.0, down from $928000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $3.5 million in Q4 2022, with the low at $821000.0 in Q1 2026.
- Historically, Other Non-Current Assets has averaged $2.0 million across 5 years, with a median of $1.9 million in 2025.
- The largest YoY upside for Other Non-Current Assets was 150.57% in 2023 against a maximum downside of 65.62% in 2023.
- Exicure's Other Non-Current Assets stood at $3.5 million in 2022, then tumbled by 65.62% to $1.2 million in 2023, then advanced by 13.08% to $1.4 million in 2024, then plunged by 31.61% to $928000.0 in 2025, then retreated by 11.53% to $821000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $821000.0 (Q1 2026), $928000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 821,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 821,000.00 |
| Dec 31, 2025 | 928,000.00 |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.44 Mn |
| Mar 31, 2024 | 2.88 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Mar 31, 2023 | 3.31 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 9.33 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 1.44 Mn |